RFQ: Syndromic Panel Polymerase Chain Reaction (PCR) Testing System (Brand Name or Equal)

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with FAR Part 13.5 for Certain Commercial Items, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; a quote is being requested, and a written solicitation document will not be issued.

This solicitation is issued as a Request for Quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2024-03 (eff. 2/23/2024), VAAR Update 2008-37 (eff. 07/28/2023), Acquisition Policy Flash 23-15 (eff. 07/28/2023). Contractor is required to be actively registered in the System for Award Management (SAM).

Vendor quote may be considered non-compliant and rejected if the Contracting Officer is unable to verify registration and certification status. The Michael E. DeBakey VA Medical Center (MEDVAMC), Microbiology, 2002 Holcombe Blvd, Houston, Texas 77030 is seeking a contractor to provide Syndromic Panel Polymerase Chain Reaction (PCR) Testing System (Brand Name or Equal). This solicitation is Unrestricted and is open to all concerns.

The government expects this announcement to result in a Firm-Fixed Price Single-Award contract. See attached RFQ... The purpose of this amendment 0001 is to provide a notice of RFQ extension to all potential vendors, see attached RFQ_A0001...